Phibro Animal Health Corp
PAHC30.676USD
+0.556+1.85%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
1.24BMarktkapitalisierung
39.11KGV TTM
mehr Informationen über Phibro Animal Health Corp Unternehmen
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Unternehmensinformationen
BörsenkürzelPAHC
Name des UnternehmensPhibro Animal Health Corp
IPO-datumApr 11, 2014
Gegründet am2014
CEOMr. Jack C. Bendheim
Anzahl der mitarbeiter1940
WertpapierartOrdinary Share
GeschäftsjahresendeApr 11
AddresseGlenpointe Centre East, 3Rd Floor
StadtTEANECK
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl07666
Telefon12013297300
Websitehttps://www.pahc.com/
BörsenkürzelPAHC
IPO-datumApr 11, 2014
Gegründet am2014
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
30.00K
+20.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
--
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
--
--
Ms. Judith A. Weinstein
Ms. Judith A. Weinstein
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
--
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
--
--
Ms. Joyce J. Lee
Ms. Joyce J. Lee
Independent Director
Independent Director
--
--
Mr. Todd Armstrong
Mr. Todd Armstrong
President - North American Region
President - North American Region
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
30.00K
+20.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
--
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
MFAs and Other
181.65M
52.22%
Nutritional specialties
43.35M
12.46%
Vaccines
33.38M
9.60%
Nach RegionUSD
Name
Umsatz
Anteil
United States
209.94M
60.36%
Latin America and Canada
70.75M
20.34%
Europe & Middle East & Africa
38.91M
11.19%
Asia Pacific
28.22M
8.11%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
MFAs and Other
181.65M
52.22%
Nutritional specialties
43.35M
12.46%
Vaccines
33.38M
9.60%
Aktionärsstatistik
Aktualisiert: Sat, May 17
Aktualisiert: Sat, May 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
15.24%
The Vanguard Group, Inc.
7.45%
State Street Global Advisors (US)
4.52%
Acadian Asset Management LLC
3.84%
Pzena Investment Management, LLC
3.55%
Other
65.40%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
15.24%
The Vanguard Group, Inc.
7.45%
State Street Global Advisors (US)
4.52%
Acadian Asset Management LLC
3.84%
Pzena Investment Management, LLC
3.55%
Other
65.40%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
50.21%
Investment Advisor/Hedge Fund
40.46%
Hedge Fund
9.57%
Research Firm
2.71%
Pension Fund
1.84%
Individual Investor
0.45%
Bank and Trust
0.41%
Corporation
0.29%
Sovereign Wealth Fund
0.05%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
373
21.59M
106.02%
-2.97M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
2023Q2
341
20.61M
101.32%
-2.12M
2023Q1
350
20.77M
102.13%
-2.00M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
3.10M
15.24%
-58.95K
-1.86%
Mar 31, 2025
The Vanguard Group, Inc.
1.52M
7.45%
+6.78K
+0.45%
Mar 31, 2025
State Street Global Advisors (US)
920.19K
4.52%
-26.64K
-2.81%
Mar 31, 2025
Acadian Asset Management LLC
782.94K
3.84%
+4.14K
+0.53%
Mar 31, 2025
Pzena Investment Management, LLC
723.83K
3.55%
-578.95K
-44.44%
Mar 31, 2025
Renaissance Technologies LLC
705.30K
3.46%
+147.50K
+26.44%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
643.91K
3.16%
-73.20K
-10.21%
Mar 31, 2025
Geode Capital Management, L.L.C.
547.09K
2.69%
+31.11K
+6.03%
Mar 31, 2025
Brandes Investment Partners, L.P.
484.75K
2.38%
-177.22K
-26.77%
Mar 31, 2025
Nuveen LLC
481.80K
2.37%
-105.20K
-17.92%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sun, Jul 6
Aktualisiert: Sun, Jul 6
Name
Anteil
Brandes US Small-Mid Cap Value ETF
1.71%
Innovator IBD Breakout Opportunities ETF
1.36%
Inspire Fidelis Multi Factor ETF
1.17%
Invesco S&P SmallCap 600 Pure Growth ETF
0.7%
Lattice Hartford Multifactor Small Cap ETF
0.63%
SPDR S&P Pharmaceuticals ETF
0.61%
Invesco Dorsey Wright SmallCap Momentum ETF
0.4%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.36%
Invesco S&P SmallCap Health Care ETF
0.35%
Zacks Small/Mid Cap ETF
0.28%
Mehr Anzeigen
Brandes US Small-Mid Cap Value ETF
Anteil1.71%
Innovator IBD Breakout Opportunities ETF
Anteil1.36%
Inspire Fidelis Multi Factor ETF
Anteil1.17%
Invesco S&P SmallCap 600 Pure Growth ETF
Anteil0.7%
Lattice Hartford Multifactor Small Cap ETF
Anteil0.63%
SPDR S&P Pharmaceuticals ETF
Anteil0.61%
Invesco Dorsey Wright SmallCap Momentum ETF
Anteil0.4%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Anteil0.36%
Invesco S&P SmallCap Health Care ETF
Anteil0.35%
Zacks Small/Mid Cap ETF
Anteil0.28%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
97.17M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
May 01, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 28, 2023 going ex on Jun 06, 2023
Jun 07, 2023
Jun 28, 2023
Jun 06, 2023
Feb 06, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 22, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 22, 2023
Feb 28, 2023
Nov 07, 2022
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 21, 2022 going ex on Nov 29, 2022
Nov 30, 2022
Dec 21, 2022
Nov 29, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
